Clinical Trial: Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title: The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurit

Brief Summary: To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.

Detailed Summary:
Sponsor: Sheba Medical Center

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Sheba Medical Center

Dates:
Date Received: June 19, 2006
Date Started: April 2006
Date Completion: December 2006
Last Updated: June 19, 2006
Last Verified: June 2006